T. Kisnanto et al.: Radioprotection 2025, 60( 3), 285 – 292 291
Reviewing. D. A Suryandari: Conceptualization, methodology, investigation, reviewing.
References
Berthel E, Ferlazzo ML, Devic C, Bourguignon M, Foray N. 2019. What does the history of research on the repair of DNA doublestrand breaks tell us?— a comprehensive review of human radiosensitivity. Int J Mol Sci. 20. https:// doi. org / 10.3390 / ijms20215339
Cai Z, Chen Z, Bailey KE, Scollard DA, Reilly RM, Vallis KA. 2008. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF. J Nucl Med 49: 1353 – 1361.
Chen Z, Wakabayashi H, Kuroda R, Mori H, Hiromasa T, Kayano D, Kinuya S. 2024. Radiation exposure lymphocyte damage assessed by g-H2AX level using flow cytometry. Sci Rep. 14. https:// doi. org / 10.1038 / s41598-024-54986-x
Denoyer D, Lobachevsky P, Jackson P, Thompson M, Martin OA, Hicks RJ. 2015. Analysis of177Lu-DOTA-octreotate therapyinduced DNA damage in peripheral blood lymphocytes of patients with neuroendocrine tumors. J Nucl Med 56: 505 – 511.
Derlin T, Bogdanova N, Ohlendorf F, Ramachandran D, Werner RA, Ross TL, Christiansen H, Bengel FM, Henkenberens C. 2021. Assessment of g-H2AX and 53BP1 foci in peripheral blood lymphocytes to predict subclinical hematotoxicity and response in somatostatin receptor-targeted radionuclide therapy for advanced gastroenteropancreatic neuroendocrine tumors. Cancers( Basel). 13. https:// doi. org / 10.3390 / can cers13071516
Dewaraja Y, Frey ED, Hobbs R, Sc D, Xiao, Y. 2022. Current status of radiopharmaceutical therapy. Int J Radiat Oncol Biol Phys 109: 891 – 901.
Djuzenova CS, Elsner I, Katzer A, Worschech E, Distel LV, Flentje M, Polat B. 2013. Radiosensitivity in breast cancer assessed by the histone g-H2AX and 53BP1 foci. Radiat Oncol 8: 1 – 12. Djuzenova CS, Zimmermann M, Katzer A, Fiedler V, Distel LV, Gasser M, Waaga-Gasser A-M., Flentje M, Polat B. 2015. A prospective study on histone g-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapyinduced outcome. BMC Cancer 15: 1 – 10.
Ferlazzo ML, Bourguignon M, Foray N. 2017. Functional assays for individual radiosensitivity: a critical review. Semin Radiat Oncol 27: 310 – 315.
Fu H, Huang J, Zhao T, Wang H, Chen Y, Xu W, Pang Y, Guo W, Sun L, Wu H, Xu P, Su B, Zhang J, Chen X, Chen H. 2023. Fibroblast activation protein-targeted radioligand therapy with 177Lu-EB- FAPI for metastatic radioiodine-refractory thyroid cancer: Firstin-human, dose-escalation study. Clin Cancer Res 29: 4740 – 4750.
Gong F, Miller KM. 2019. Histone methylation and the DNA damage response. Mutat Res � Rev 780: 37 – 47.
Huang R-X., Zhou P-K. 2020. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther 5. https:// doi. org / 10.1038 / s41392-020-0150-x
Kawashima S, Kawaguchi N, Taniguchi K, Tashiro K, Komura K, Tanaka T, Inomata Y, Imai Y, Tanaka R, Yamamoto M, Inoue Y, Lee SW, Kawai M, Tanaka K, Okuda J, Uchiyama K. 2020. g-H2AX as a potential indicator of radiosensitivity in colorectal cancer cells. Oncol Lett https:// doi. org / 10.3892 / ol. 2020.11788
Khazaei Monfared Y, Heidari P, Klempner SJ, Mahmood U, Parikh AR, Hong TS, Strickland MR, Esfahani SA. 2023. DNA damage by radiopharmaceuticals and mechanisms of cellular repair. Pharmaceutics 15: 1 – 26.
Lassmann M, Hänscheid H, Gassen D, Biko J, Meineke V, Reiners C, Scherthan H. 2010. In vivo formation of g-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer. J Nucl Med 51: 1318 – 1325.
Li P, Du C-r, Xu W-c, Shi Z, Zhang Q, Li Z. 2013 Correlation of dynamic changes in g-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiationinduced oral mucositis. Radiat Oncol 8: 155.
Liu T-T., Li C-F., Tan K-T., Jan Y-H., Lee P-H., Huang C-H., Yu S, Tsao C, Wang J, Huang H. 2022. Characterization of aberrations in DNA damage repair pathways in gastrointestinal stromal tumors: Cancers( Basel) 1 – 22.
Lobachevsky P, Leong T, Daly P, Smith J, Best N, Tomaszewski J, Thompson ER, Li N, Campbell IG, Martin RF, Martin OA. 2016. Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity. Cancer Lett 383: 212 – 219.
Mahmoud AS, Hassan AME, Ali AA, Hassan NM, Yousif AA, Elbashir FE, Omer A, Abdalla OM. 2022. Detection of radiationinduced DNA damage in breast cancer using gamma H2AX biomarker: a possible correlation with their body mass index. Genome Integr 13.
Purnami S, Suvifan VA, Ramadhani D, Lusiyanti Y, Darlina D, Rahajeng N, Syaifudin M, Pujianto DA, Widowati R. 2023. Phosphorylated Ataxia Telangiectasia Mutated( pATM) Enzyme- Linked Immunosorbent Assay( ELISA) for predicting radiation induces normal tissue toxicity in radiotherapy patients: a systematic review. Indones J Cancer 17: 235.
Raavi V, Perumal FD, Paul S. 2021. Potential application of g-H2AX as a biodosimetry tool for radiation triage. Mutat Res � Rev 787: 108350.
Ramadhani D, Syaifudin M, Purnami S, Naroeni A. 2020. The use of image processing and analysis in automated biological dosimetry. Atom Indones 46: 127 – 133.
Richardson RB. 2011. Stem cell niches and other factors that influence the sensitivity of bone marrow to radiation-induced bone cancer and leukaemia in children and adults. Int J Rad Biol 87: 343 – 359.
Sak A, Grehl S, Erichsen P, Engelhard M, Grannaß A, Levegrün S, Stuschke M. 2007. Gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: dependence on the dose-distribution, irradiated site and time from start of treatment. Int J Rad Biol 83: 639 – 652.
Sgouros G, Bodei L, McDevitt MR, Nedrow JR. 2020. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discov 19: 589 – 608.
Song H, Shen R, Liu X, Yang X, Xie K, Guo Z, Wang D. 2023. Histone post-translational modification and the DNA damage response. Genes Dis 10: 1429 – 1444.
Srivastava N, Gochhait S, de Boer P, Bamezai RNK. 2009. Role of H2AX in DNA damage response and human cancers. Mutat Res � Rev 681: 180 – 188.
Vinnikov V, Belyakov O. 2022. Clinical applications of biological dosimetry in patients exposed to low dose radiation due to radiological, imaging or nuclear medicine procedures. Semin Nucl Med. 52: 114 – 139.